Hypermarcas (OTCMKTS:HYPMY) Announces Earnings Results, Beats Expectations By $0.01 EPS

Hypermarcas (OTCMKTS:HYPMY) issued its quarterly earnings results on Thursday. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.01, Zacks reports. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%.

Hypermarcas Stock Performance

Shares of OTCMKTS HYPMY traded up $0.07 during trading on Friday, hitting $4.20. 58,852 shares of the company were exchanged, compared to its average volume of 22,311. Hypermarcas has a 12-month low of $3.71 and a 12-month high of $5.50. The company has a fifty day moving average price of $4.10 and a 200-day moving average price of $4.36. The firm has a market capitalization of $2.96 billion, a PE ratio of 8.75 and a beta of 0.70.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. Jefferies Financial Group raised shares of Hypermarcas to a “strong-buy” rating in a research note on Monday, July 20th. Zacks Research raised Hypermarcas to a “hold” rating in a report on Wednesday, April 29th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy”.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.